Back to Search
MELISSA DELBELLO, MD
MD
Child & Adolescent Psychiatry Physician
NPI: 1609956101IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry Physician
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
35 071111(OH)
Child & Adolescent Psychiatry PhysicianPrimary
Psychiatry & Neurology — Child & Adolescent Psychiatry
Code: 2084P0804X
35-07-1111(OH)
CMS Specialties
PrimaryPSYCHIATRY
Education
UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY
Class of 1995
Clinical Trials (4)
4
Linked Trials
0
Recruiting
4
With Results
Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine
NCT00394095COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
NCT00845507COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania
NCT00393978COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults
NCT00550394COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
A double-blind, placebo-controlled trial of exenatide for the treatment of olanzapine-related weight gain in obese and overweight adults.
PMID 40203970·J Affect Disord·2025
2-rct
A Double-Blind, Placebo-Controlled Study of Adjunctive Topiramate in Adolescents With Co-Occurring Bipolar and Cannabis Use Disorders.
PMID 39697396·JAACAP Open·2024
8-other
A Double-Blind Placebo-Controlled Pilot Study of Topiramate in Manic Adolescents Treated with Olanzapine.
PMID 37130314·J Child Adolesc Psychopharmacol·2023
2-rct
A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
PMID 19624387·Bipolar Disord·2009
4-observational
Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder.
PMID 18928413·J Child Adolesc Psychopharmacol·2008
2-rct
Neuroanatomical characterization of child offspring of bipolar parents.
PMID 18356766·J Am Acad Child Adolesc Psychiatry·2008
8-other
Pharmacological management of bipolar disorder in a youth with diabetes.
PMID 17885580·J Am Acad Child Adolesc Psychiatry·2007
5-case
A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder.
PMID 17503991·J Clin Psychiatry·2007
2-rct
Response and remission in adolescent mania: signal detection analyses of the young mania rating scale.
PMID 17450054·J Am Acad Child Adolesc Psychiatry·2007
8-other
Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode.
PMID 17403971·Am J Psychiatry·2007
5-case
Acute dystonia associated with aripiprazole in a child.
PMID 17314714·J Am Acad Child Adolesc Psychiatry·2007
5-case
Pharmacological interventions for bipolar youth: developmental considerations.
PMID 17064436·Dev Psychopathol·2006
6-review
The neurophysiology of childhood and adolescent bipolar disorder.
PMID 16641835·CNS Spectr·2006
4-observational
A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania.
PMID 16540815·J Am Acad Child Adolesc Psychiatry·2006
2-rct
Open-label lithium for the treatment of adolescents with bipolar depression.
PMID 16540813·J Am Acad Child Adolesc Psychiatry·2006
3-trial
Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study.
PMID 16292323·Neuropsychopharmacology·2006
3-trial
A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder.
PMID 15908836·J Am Acad Child Adolesc Psychiatry·2005
3-trial
Parametric neurocognitive task design: a pilot study of sustained attention in adolescents with bipolar disorder.
PMID 15571793·J Affect Disord·2004
8-other
Neurochemical predictors of response to pharmacologic treatments for bipolar disorder.
PMID 15538996·Curr Psychiatry Rep·2004
6-review
Phenomenology and epidemiology of childhood psychiatric disorders that may necessitate treatment with atypical antipsychotics.
PMID 15104522·J Clin Psychiatry·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 234 GOODMAN ST, PSYCHIATRY
CINCINNATI, OH 45219 - Phone
- (513) 558-7700
Quick Facts
- NPI
- 1609956101
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 31
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile